3.3822
Schlusskurs vom Vortag:
$3.80
Offen:
$3.72
24-Stunden-Volumen:
652.85K
Relative Volume:
1.37
Marktkapitalisierung:
$34.46M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.51
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
-18.81%
1M Leistung:
-43.78%
6M Leistung:
+52.74%
1J Leistung:
+34.34%
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Vergleichen Sie IBIO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IBIO
iBio Inc
|
3.345 | 34.46M | 2.05M | -23.15M | -16.93M | -6.6319 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
480.81 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
587.50 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
559.07 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
244.92 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
239.78 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-05-28 | Eingeleitet | Chardan Capital Markets | Buy |
2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
iBio Inc Aktie (IBIO) Neueste Nachrichten
iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World
iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World
iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World
Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World
iBio Inc. stock rises Monday, outperforms market - MarketWatch
$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq
iBio Inc. stock rises Friday, outperforms market - MarketWatch
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio stock soars to 52-week high, reaches $5.03 - Investing.com
iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, still outperforms market - MarketWatch
iBio, Inc. Advances in Therapeutics and Leadership - TipRanks
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
iBio Announces Transfer to Nasdaq Capital Market - TipRanks
Can iBio's Nasdaq Move Transform Its Market Presence? Key Details Revealed - StockTitan
Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year? - Insider Monkey
10 Stocks Insiders Are Buying This Year - Insider Monkey
Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges - TipRanks
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
SEC Form 424B3 filed by iBio Inc. - Quantisnow
iBio Inc. stock falls Monday, underperforms market - MarketWatch
iBio Inc. (IBIO) reports earnings - Quartz
iBio, Inc. Reports Second Quarter Fiscal 2025 Financial Results and Corporate Updates on Advancements in Cardiometabolic Therapeutics - Nasdaq
iBio Reports Fiscal Second Quarter 2025 Financial Results - GlobeNewswire
IBIO's Strategic Pivot: AI-Powered Antibody Discovery Shows Promise Despite Q2 Losses - StockTitan
A Tale of Resilience: iBio Inc Amid Stock Market Turbulence - The InvestChronicle
iBio (IBIO) Projected to Post Quarterly Earnings on Friday - Defense World
iBio (NYSE:IBIO) Trading Up 4% – Time to Buy? - Defense World
iBio (NYSEMKT:IBIO) Trading Up 1.3% – Still a Buy? - Defense World
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):